Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-02-27
2007-02-27
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S237200, C514S254010, C514S326000, C514S422000, C544S141000, C544S372000, C546S208000, C548S518000, C548S953000
Reexamination Certificate
active
10776828
ABSTRACT:
The present application describes modulators of MCP-1 of formula (I):or pharmaceutically acceptable salt forms thereof, useful for the prevention of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma, processes for preparing and intermediates thereof.
REFERENCES:
patent: 5356907 (1994-10-01), Clemence et al.
patent: 6011052 (2000-01-01), Padia et al.
patent: 6706712 (2004-03-01), Cherney
patent: 2003/0060459 (2003-03-01), Cherney et al.
patent: 2003/0216434 (2003-11-01), Cherney
patent: 2004/0110736 (2004-06-01), Cherney
patent: 2004/0186143 (2004-09-01), Carter et al.
patent: 2004/0235835 (2004-11-01), Carter
patent: 2004/0235836 (2004-11-01), Cherney
patent: WO 97/37975 (1997-10-01), None
patent: WO 97/44329 (1997-11-01), None
patent: WO 98/06703 (1998-02-01), None
patent: WO 98/08826 (1998-03-01), None
patent: WO 99/07351 (1999-02-01), None
patent: WO 99/07678 (1999-02-01), None
patent: WO 99/25686 (1999-05-01), None
patent: WO 99/37304 (1999-07-01), None
patent: WO 9937304 (1999-07-01), None
patent: WO 99/40913 (1999-08-01), None
patent: WO 99/40914 (1999-08-01), None
patent: WO 00/46196 (2000-08-01), None
patent: WO 00/69815 (2000-11-01), None
patent: WO 00/69820 (2000-11-01), None
patent: WO 01/19939 (2001-03-01), None
patent: WO 02/01416 (2002-01-01), None
patent: WO 02/26734 (2002-04-01), None
patent: WO 02/50019 (2002-06-01), None
patent: WO 02/060859 (2002-08-01), None
patent: WO 02060859 (2002-08-01), None
patent: WO 02/070523 (2002-09-01), None
patent: WO 02/102372 (2002-12-01), None
patent: WO 03/43988 (2003-05-01), None
patent: WO 03075853 (2003-09-01), None
patent: WO 2004071449 (2004-08-01), None
patent: WO 2004098512 (2004-11-01), None
patent: WO 2004098516 (2004-11-01), None
Suga et al., “Glycosidase Antibodies Induced to a Half-Chair Transition-State Analog,”J. Am. Chem. Soc.,vol. 116, pp. 11197-11198, 1994.
Fujita et al., “Regiocontrolled Iodoaminocyclization Reaction of an Ambident Nucleophile Mediated by Basic Metallic Reagent,”J. Org. Chem.,vol. 62 pp. 7330-7335, 1997.
U.S. Appl. No. 10/922,406, filed Aug. 19, 2004, Carter et al.
U.S. Appl. No. 10/923,619, filed Aug. 19, 2004, Carter et al.
U.S. Appl. No. 10/922,726, filed Aug. 19, 2004, Carter et al.
U.S. Appl. No. 10/923,538, filed Aug. 19, 2004, Carter et al.
Carter Percy H.
Cherney Robert J.
Duncia John V.
Gardner Daniel S.
Santella Joseph B.
Bristol--Myers Squibb Company
Kosack Joseph R.
Saeed Kamal A.
VanAtten Mary K.
LandOfFree
Cyclic derivatives as modulators of chemokine receptor activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic derivatives as modulators of chemokine receptor activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic derivatives as modulators of chemokine receptor activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3839383